(DMAC) |
| 0 (0%) 10-12 13:46 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 10.08 |
| Resistance 1: | 8.63 |
| Pivot price: | 8.10 |
| Support 1: | 7.19 |
| Support 2: | 6.30 |
| 52w High: | |
| 52w Low: |
| EPS | -0.720 |
| Book Value | 0.710 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -64.1 |
| Return on Equity (ttm) | -114.6 |
Wed, 07 Oct 2026
(DMAC) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Fri, 02 Oct 2026
Diamedica Therapeutics Inc (DMAC-Q) Stock Price and News - The Globe and Mail
Thu, 24 Sep 2026
DMAC Foundation revs up for Saturday car show on The Square - Athens The News Courier
Tue, 22 Sep 2026
We're Hopeful That DiaMedica Therapeutics (NASDAQ:DMAC) Will Use Its Cash Wisely - Simply Wall Street
Sat, 19 Sep 2026
Wall Street Analysts Think DiaMedica Therapeutics (DMAC) Could Surge 129.97%: Read This Before Placing a Bet - Eastern Progress
Wed, 26 Aug 2026
Should I buy DiaMedica Therapeutics (DMAC) - Zacks Investment Research
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |